Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, announces new additions to two of its clinically proven product lines: ELASTIderm Eye Complete Complex Serum™ and CLENZIderm M.D. Normal to Oily System. ELASTIderm Eye Complete Complex Serum is the latest member of the ELASTIderm Eye family of products. The Complete Complex Serum is formulated with a proprietary bi-mineral complex and malonic acid, which in combination have been shown to improve the appearance of fine lines and wrinkles around the eye. “Our ELASTIderm line has been incredibly successful, attaining nearly 30% market share in our space, largely because of the results it delivers,” said Jim Hartman, Vice President of Global Marketing and Business Development at Obagi Medical Products. “But our users have been asking for more options to address additional concerns, specifically puffiness under the eye. We are pleased to give them exactly what they have been asking for in this new, gently delivered Serum.” The innovative stainless steel rollerball applicator provides a soothing effect and optimized delivery of the Serum to assist in improving the appearance of puffiness under the eye. Used twice daily for best results, ELASTIderm Eye Complete Complex Serum also includes caffeine to energize the skin under the eye. In a recent study, consumers reported that the results met or exceeded their expectations, stating that the ELASTIderm Eye Complete Complex Serum was better than the eye product they were currently using. 1 Additionally, the new and improved CLENZIderm M.D. Normal to Oily System is now available, joining the existing Normal to Dry System. The system includes Daily Care Foaming Cleanser (two percent salicylic acid), Pore Therapy (two percent salicylic acid) and Therapeutic Lotion (five percent benzoyl peroxide) for clear skin, fast. This new System is clinically proven to deliver clearer, healthier skin in just two weeks. 2 OBAGI ELASTIderm Eye Complete Complex Serum is available for purchase in dermatology, plastic surgery and other aesthetic physicians’ practices. OBAGI CLENZIderm M.D. Normal to Oily System includes Daily Care Foaming Cleanser, Pore Therapy and Therapeutic Lotion and is available for purchase in dermatology, plastic surgery and other aesthetic physicians’ practices.
About Obagi Medical Products, Inc.Obagi Medical Products is a specialty pharmaceutical company that develops, markets and sells, and is a leading provider of, proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market. Using its Penetrating Therapeutics™ technologies, Obagi Medical's products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, rosacea, and soft tissue deficits, such as fine lines and wrinkles. Obagi Medical’s portfolio, which includes cosmetic, over-the-counter and prescription products, including 4% hydroquinone, is sold and promoted only through physician offices and requires education by a physician on proper use. The history of Obagi's skin care product introductions is as follows: Obagi Nu-Derm®, Obagi-C® Rx (a prescription-strength vitamin C and hydroquinone system), Obagi® Professional-C (a line of highly stable vitamin C serums), Obagi Condition &Enhance® for use with cosmetic procedures to enhance patient outcomes and satisfaction, Obagi ELASTIderm® Eye Products and Obagi CLENZIderm® M.D. acne therapeutic systems, a formulation of Obagi CLENZIderm M.D. Systems for normal to dry skin, and Obagi ELASTIderm Décolletage System, Obagi Rosaclear® System, Obagi ELASTILash® Eyelash Solution, Obagi Blue Peel RADIANCE ®, and Nu-Derm® Sun Shield SPF 50. Visit www.obagi.com for information. Penetrating Therapeutics is a trademark, and Obagi, the Obagi logo, Blue Peel RADIANCE, Condition & Enhance, ELASTIderm, ELASTILash, Nu-Derm, Obagi-C, Obagi CLENZIderm and Rosaclear are registered trademarks, of Obagi Medical Products, Inc. and/or its affiliates in the United States and certain other countries. 1 OMP, Inc. Data on file. 2 OMP, Inc. Data on file.